• No results found

L-lactide-co-glycolide)

Fabrication of electrospun poly(d,l lactide-co-glycolide)80/20 scaffolds loaded with diclofenac sodium for tissue engineering

Fabrication of electrospun poly(d,l lactide-co-glycolide)80/20 scaffolds loaded with diclofenac sodium for tissue engineering

... Background: Adaptation of nanotechnology into materials science has also advanced tissue engineering research. Tissues are basically composed of nanoscale structures hence making nanofibrous materials closely resemble ...

8

Controlled-release of tetracycline and lovastatin by poly(D,L-lactide-co-glycolide acid)-chitosan nanoparticles enhances periodontal regeneration in dogs

Controlled-release of tetracycline and lovastatin by poly(D,L-lactide-co-glycolide acid)-chitosan nanoparticles enhances periodontal regeneration in dogs

... acid) (PLGA) nanoparticles. The aim of this study was to develop a local delivery device, PLGA-lovastatin-chitosan-tetracycline nanoparticles, which allows the sequential release of tetracycline and lovastatin to ...

13

Antitumoral activity of L-ascorbic acid-poly-D,L-(lactide-co-glycolide) nanoparticles containing violacein

Antitumoral activity of L-ascorbic acid-poly-D,L-(lactide-co-glycolide) nanoparticles containing violacein

... Abstract: It has been demonstrated that tumoral cells have a higher uptake of ascorbic acid compared to normal cells. This differential characteristic can be used as a way to improve the specificity of antitumoral ...

9

Synthesis and Characterization of Poly(D,L Lactide co Glycolide) Copolymer

Synthesis and Characterization of Poly(D,L Lactide co Glycolide) Copolymer

... The copolymer poly(D,L-lactide-co-glycolide) is one of the most interesting polymers for medical applications. This interest is justified by the fact that it is bioreabsorbable, biocompatible ...

18

Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes

Physicochemical features and transfection properties of chitosan/poloxamer <br />188/poly(D,L-lactide-co-glycolide) nanoplexes

... Abstract: The aim of this study was the evaluation of the effects of two emulsifiers on the physicochemical and technological properties of low molecular weight chitosan/poly ...

14

Interaction of Immune System Protein with PEGylated and Un PEGylated Polymeric Nanoparticles

Interaction of Immune System Protein with PEGylated and Un PEGylated Polymeric Nanoparticles

... (D, L-lactide-co-glycolide) (PLGA), polylactic acid (PLA), gelatin and poly-alkyl-cyano-acrylates (PACA) are attracting a great deal of research interest due to their potential to deliver ...

11

Electric Conductivity of Electrolytic Copper Powder Filled Poly(Lactide-co-Glycolide) Composites

Electric Conductivity of Electrolytic Copper Powder Filled Poly(Lactide-co-Glycolide) Composites

... 0.4 vol. % – 7.2 vol. % of copper powder filled PLGA polymer composites were prepared. Also, the reference samples consisting of pure PLGA and pressed copper powder were prepared. ...

13

Novel docetaxel loaded nanoparticles based on poly(lactide co caprolactone) and poly(lactide co glycolide co caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies

Novel docetaxel loaded nanoparticles based on poly(lactide co caprolactone) and poly(lactide co glycolide co caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies

... Poly(L-lactide- co-caprolactone-co-glycolide) (PLGA-PCL) (L-lactide: glycolide:caprolactone 70:10:20 molar ratio, inherent viscosity ...

9

Poly(d,l-lactide-co-glycolide)&ndash;chitosan composite particles for the treatment of lung cancer

Poly(d,l-lactide-<em>co</em>-glycolide)&ndash;chitosan composite particles for the treatment of lung cancer

... Abstract: Tumor heterogeneity makes combination chemotherapy one of the preferred modes of treatment regimens. In this work, sequential exposure of two anticancer agents, paclitaxel (Tx) followed by topotecan (TPT), was ...

15

Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine

<em>Chlamydia trachomatis</em> recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine

... D, L-lactide-co-glycolide; PBS, phosphate-buffered saline; rMOMP, recombinant major outer membrane protein; GM-CSF, granulocyte- macrophage colony-stimulating factor; IL, interleukin; G-CSF, ...

15

Synthesis of Amorphous Polylactide and Poly(lactide-co-glycolide) Containing High L-form Enantiomer for Use in Controlled Release Drug Delivery

Synthesis of Amorphous Polylactide and Poly(lactide-co-glycolide) Containing High L-form Enantiomer for Use in Controlled Release Drug Delivery

... of L-lactide (LL) copolymerization on the properties of poly(D,L-lactide) (PDLL) and poly(D,L-lactide-co-glycolide) (PDLLG) copolymers and its drug release ...

9

OCULAR DRUG DELIVERY: A REVIEW

OCULAR DRUG DELIVERY: A REVIEW

... (D, L- lactide-co- glycolide) (PLGA) polymers are biocompatible and biodegradable nature, the most studied polymer for the ocular drug ...and lactide: glycolide ...

11

FORMULATION AND EVALUATION OF BSA LOADED PLGA MICROPARTICLES

FORMULATION AND EVALUATION OF BSA LOADED PLGA MICROPARTICLES

... (D, L-lactide-co-glycolide) (PLGA) microspheres containing bovine serum albumin (BSA) as a model drug and to evaluate the various physicochemical characteristics of the formulations, namely ...

9

Fabrication of Biodegradable Polymeric Microspheres with Controllable Porous Structure for Cell Delivery

Fabrication of Biodegradable Polymeric Microspheres with Controllable Porous Structure for Cell Delivery

... Poly(D,L-lactide-co-glycolide) (PLGA, 75:25, Mw~106000) was purchased from Birmingham Polymers (Pelham, AL, USA). Gelatin (type A, from porcine skin), PVA (Mw13 000–23 000, 98% hydrolyzed), ...

8

Increased survival rate by local release of diclofenac in a murine model of recurrent oral carcinoma

Increased survival rate by local release of diclofenac in a murine model of recurrent oral carcinoma

... Abstract: Despite aggressive treatment with radiation and combination chemotherapy following tumor resection, the 5-year survival rate for patients with head and neck cancer is at best only 50%. In this study, we ...

11

Development of novel cationic chitosan- and anionic alginate&ndash;coated poly(D,L-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol

Development of novel cationic chitosan- and anionic alginate&ndash;coated poly(D,L-lactide-<em>co</em>-glycolide) nanoparticles for controlled release and light protection of resveratrol

... Background: Resveratrol, like other natural polyphenols, is an extremely photosensitive compound with low chemical stability, which limits the therapeutic application of its beneficial effects. The development of ...

16

Benefits of biphasic calcium phosphate hybrid scaffold-driven osteogenic differentiation of mesenchymal stem cells through upregulated leptin receptor expression

Benefits of biphasic calcium phosphate hybrid scaffold-driven osteogenic differentiation of mesenchymal stem cells through upregulated leptin receptor expression

... A composite system was developed using poly(lactide-co- glycolide) (PLGA) copolymer, coralline HA, BCP ceramics, and collagen as a carrier matrix for MSCs. PLGA (300 mg; Boehringer Ingelheim, ...

10

Induction of long lasting protective immunity against Toxoplasma gondii in BALB/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide co glycolide) microparticles

Induction of long lasting protective immunity against Toxoplasma gondii in BALB/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide co glycolide) microparticles

... We then determined whether PLG-rSAG1 microparti- cles could confer effective protection in mice. Eight weeks after boosting (the 10th week), all groups of 10 mice each were subcutaneously challenged with 1 × 10 4 live ...

12

Glycosaminoglycan-functionalized poly-lactide-co-glycolide nanoparticles: synthesis, characterization, cytocompatibility, and cellular uptake

Glycosaminoglycan-functionalized poly-lactide-co-glycolide nanoparticles: synthesis, characterization, cytocompatibility, and cellular uptake

... µ L of LDH was used to validate the ...µ L of the medium was transferred to a fresh 96-well ...µ L of LDH reaction mixture for 15 minutes at room temperature and the absorbance was measured at 450 nm ...

15

Robust aptamer&ndash;polydopamine-functionalized M-PLGA&ndash;TPGS nanoparticles for targeted delivery of docetaxel and enhanced cervical cancer therapy

Robust aptamer&ndash;polydopamine-functionalized M-PLGA&ndash;TPGS nanoparticles for targeted delivery of docetaxel and enhanced cervical cancer therapy

... Here, we reported a robust aptamer–polydopamine-functionalized mannitol-functionalized poly(lactide-co-glycolide) (M-PLGA)– d - α -tocopheryl polyethylene glycol 1000 succinate (TPGS) [r] ...

13

Show all 10000 documents...

Related subjects